Sorrento Therapeutics, Inc. Gains 39.59%
Fri, Jan 10, 2020 at 05:30 PM
Sorrento Therapeutics, Inc. (SRNE:NASDAQ) soared at $4.76, a gain of 39.6%. The stock got featured on our News Catalysts scanner on Fri 10 Jan 20 at 08:02 AM in the 'ACQUISITION' category. From Wed 18 Dec 19, the stock recorded 50.00% Up Days and 53.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About Sorrento Therapeutics, Inc. (SRNE:NASDAQ)
Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases.
Top 10 Gainers:
- CounterPath Corporation (CPAH:NASDAQ), 304.12%
- Origin Agritech Limited (SEED:NASDAQ), 46.92%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 42.67%
- Sorrento Therapeutics, Inc. (SRNE:NASDAQ), 39.59%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%
- Lianluo Smart Limited (LLIT:NASDAQ), 28.57%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 28.54%
- Akari Therapeutics, Plc (AKTX:NASDAQ), 25.43%
- Aileron Therapeutics, Inc. (ALRN:NASDAQ), 24.97%
- Nektar Therapeutics (NKTR:NASDAQ), 24.69%